Current Search Criteria: Intervention: BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF
Found 22 matching trials
Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions PHASE2 The patients are being offered a stem cell transplant. Stem cells are very ...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma PHASE2 This phase II trial studies how well an umbilical cord blood transplant wit...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor PHASE2 The purpose of this research study is:(1) to determine if high doses of che...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503) PHASE2 This is a clinical trial that will compare survival and sickle related outc...
Show More Location
Benioff Children's Hospital at Oakland
Learn More & Join Trial
Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors PHASE2 This study is being done to learn whether a new method to prevent rejection...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation PHASE2 The purpose of this clinical trial is to compare drug combinations to learn...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies PHASE2 This is a phase II, open-label, prospective study of T cell receptor alpha/...
Show More Location
University of Minnesota Masonic Cancer Center
Learn More & Join Trial
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy PHASE2 This is an single arm, open label, interventional phase II trial evaluating...
Show More Status
Active Not Recruiting
Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders NA RATIONALE: Giving chemotherapy with or without total-body irradiation befor...
Show More Location
Banner Good Samaritan Medical Center
Learn More & Join Trial
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders PHASE2 This is a phase II trial of T cell receptor alpha/beta depletion (α/β TCD) ...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial